About this trial
Postoperative pulmonary complications (PPC) are among the main complications after the anesthetic-surgical procedure. It can be said that thoracic surgery results in impaired respiratory function in the postoperatively, due to the decrease in lung volumes and capacities (the vital capacity decreases by approximately 50-60% and functional residual capacity decreases by approximately 30% in the first 24 hours after surgery) diaphragm dysfunction, gas exchange impaired, cough and ineffective mucociliary clearance. Thus, our hypothesis is that the application of preoperative risk scores normally used for non-cardiac and non-thoracic surgeries may be effective on the predictability of the occurrence of CPP in patients undergoing ventilation single-lung. This is a prospective observational study in order to evaluate the performance of the ASA, ARISCAT and LAS VEGAS risk scores for predict the occurrence of postoperative pulmonary complications (PPC) in patients undergoing thoracic surgery with single-lung ventilation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients undergoing any thoracic procedure associated with intraoperative single-lung ventilation.
Disqualifiers
Patients undergoing cardiac surgery, pregnant women, patient refusal, contraindications to proposed surgical, anesthetic or analgesic techniques, sepsis, psychiatric illness, uncontrolled endocrine, kidney or liver disease and coagulopathies.
Trial population
Adult patients undergoing any thoracic procedure associated with intraoperative use of single-lung ventilation.
Trial design
Cohort
Prospective
Treatments tested in this trial
Single-lung ventilation
Procedure/SurgeryPatients undergoing thoracic surgery and intraoperative single-lung ventilation.
Treatment groups
Trial outcomes
Primary outcomes
Postoperative pulmonary complications
Incidence of composite pulmonary complications after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.